Impedimed Limited (AU:IPD) has released an update.
Impedimed Limited has announced the cessation of over 13 million securities, including options and performance rights, due to the failure to meet certain conditions by June 30, 2024. The financial community following Impedimed may find this development significant as it could impact the company’s capital structure and future growth plans.
For further insights into AU:IPD stock, check out TipRanks’ Stock Analysis page.